Gene Therapy Market, By Vector Type, By Gene Type, By Therapy, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

List of Tables

REPORT HIGHLIGHT

Gene Therapy Market size was valued at USD 8,300 Million in 2022, expanding at a CAGR of 22.3% from 2023 to 2030.

Gene therapy is a technique that modifies a person's genes to treat or cure disease. Currently, gene therapies are being utilized to address specific conditions such as Leber congenital amaurosis, an eye disorder, and spinal muscular atrophy, a muscle disorder. However, extensive research is being conducted to ensure the safety and efficacy of numerous other gene therapies. Additionally, genome editing, a promising technique currently under investigation, holds the potential to treat various disorders in the near future. It is important to note that gene therapy products are regulated by the FDA's Center for Biologics Evaluation and Research (CBER) as they are considered biological products. Another innovative technique known as genome editing, exemplified by CRISPR-Cas9, takes a different approach by utilizing molecular tools to modify the existing DNA within cells, rather than introducing new genetic material.

Gene Therapy Market- Market Dynamics

Increase in the prevalence of chronic disorders such as cancer, rare disease genetic disorders, and others globally anticipated to drive the Gene Therapy market growth.

Gene therapy presents a promising strategy for combating cancer by specifically targeting the underlying genetic abnormalities responsible for its progression. According to the World Health Organization, there were approximately 18.1 million cancer cases worldwide in 2020, with 9.3 million affecting men and 8.8 million affecting women. While gene therapies primarily focus on addressing rare genetic disorders that lack effective traditional treatment options, the National Center for Biotechnology Information estimates that each year, 495,000 infants are born with congenital malformations, 390,000 with G6PD deficiency, 21,400 with Down syndrome, 9,000 with beta-thalassemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders. By tailoring treatment to an individual's specific genetic profile, gene therapy enables a more personalized approach to healthcare. Moreover, increased investment and funding in gene therapy research and development can create opportunities for market growth. However, the substantial cost associated with gene therapies presents challenges in terms of reimbursement and accessibility.

Gene Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global Gene Therapy market is estimated to grow annually at a CAGR of around 22.3% over the forecast period (2023-2030)

Based on Vector Type segmentation, Non-viral vectors was predicted to show maximum market share in the year 2022

Based on Gene Type segmentation, Antigen was the leading type in 2022

Based on Therapy segmentation, In Vivo Therapy was the leading type in 2022

Based on Application segmentation, Oncological Disorders was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Gene Therapy Market- Segmentation Analysis:

The Global Gene Therapy Market is segmented based on Vector Type, Gene Type, Therapy, Application, and Region.

The market is divided into three categories based on Vector Type: Viral Vector and Non-Viral Vector. The market is primarily dominated by Non-Viral Vectors. Generally, Non-viral vectors exhibit a superior safety profile compared to viral vectors, thereby minimizing the chances of immune responses or unintended side effects. Moreover, Non-viral vectors possess the capability to accommodate larger DNA payloads, enabling the delivery of more extensive genetic material.

The market is divided into two categories based on Gene Type: Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors and Others. The antigen segment dominates the market. Gene therapy plays a significant role in enhancing the immune system's ability to recognize and attack specific antigens associated with diseases.

The market is divided into three categories based on Therapy: In Vivo Therapy and Ex Vivo Therapy. In Vivo Therapy dominates the market. In Vivo Therapy holds a significant position in the market. Researchers are actively investigating in vivo gene therapy for various diseases, such as genetic disorders, specific forms of cancer, and other medical conditions. The aim is to modify the patient's genetic material to offer therapeutic advantages.

The market is divided into three categories based on Application: Oncological Disorders, Rare Diseases, Neurological Disorders and Other Diseases. The market is primarily dominated by the Oncological Disorders segment. Several gene therapies targeting oncological disorders are currently undergoing clinical trials at different stages. Certain therapies have obtained regulatory approvals for specific indications, whereas others are still in the investigational phases.

Gene Therapy Market- Geographical Insights

Geographically, this market is widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in the business. The North American region is expected to dominate the market's growth due to its highly advanced hospital infrastructure and the increasing demand for cell and gene therapy. North America boasts a robust healthcare ecosystem characterized by collaborations between academia, industry, and healthcare providers. This collaborative environment fosters innovation and expedites the translation of scientific discoveries into clinical applications. According to the American Hospital Association Information Technology, in 2018, 98.3% of hospitals had adopted Electronic Health Records (EHRs), with no differences based on Critical Access Hospital (CAH) status. Additionally, 58.7% and 55.6% of hospitals had adopted advanced Patient Engagement (PE) and Clinical Document Architecture (CDA) functions, respectively. The growing recognition of the potential of cell and gene therapies in treating various diseases, including cancer and genetic disorders, has led to an increasing demand for these therapies. The United States Food and Drug Administration (FDA) has approved four gene therapies for sale in the United States (U.S.) as of December 2022: Luxterna (voretigene neparvovec) approved in 2017, Zolgensma (onasemnogene abeparvovec-xioi) approved in 2019, Tecartus (brexucabtagene autoleucel) approved in 2020, and Hemgenix (etranacogene dezaparvovec) approved in 2022. Although still in its early stages, gene therapy holds the potential to treat and potentially cure diseases that were previously considered untreatable. Europe is projected to be the second-largest gene therapy market in the upcoming years, primarily due to the growing demand for personalized gene-based treatments.

Gene Therapy Market- Competitive Landscape:

The gene therapy market is experiencing significant growth with numerous therapies being developed for various indications. This presents a competitive landscape that requires thorough analysis to identify opportunities and challenges for gene therapy developers. In the pharmaceutical industry, the emergence of cell and gene therapy has brought about innovative treatments, with companies focusing on patents and investing strategically to introduce advanced technologies. These investments not only enhance patent portfolios but also position key players at the forefront of industry advancements. Recent deals highlight the importance of cell and gene therapy in the pharmaceutical sector, with dynamic shifts in strategic partnerships, patents, and job trends. The United States leads in global adoption, with collaborative efforts, transformative patents, and evolving job opportunities shaping the future of innovative advancements. As more gene therapies enter the market, companies must effectively prepare their products and go-to-market strategies to fulfill their promise of transforming patient lives. These companies must launch their products in a way that maximizes patient benefits while ensuring success in the market.

Recent Developments:

In Dec 22, 2021, Novartis announced that it entered into a definitive agreement to acquire all of the outstanding share capital of the UK-based ocular gene therapy company Gyroscope Therapeutics. Geographic atrophy is an advanced form of dry age-related macular degeneration leading to advanced and irreversible idea loss1.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE THERAPY MARKET KEY PLAYERS

REGENXBIO, Inc.
Oxford BioMedica plc
Dimension Therapeutics, Inc.
Bristol-Myers Squibb Company
SANOFI
Applied Genetic Technologies Corporation
F. Hoffmann-La Roche Ltd
Bluebird Bio, Inc.
Novartis AG
Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
UniQure N.V.
Shire Plc
Cellectis S.A.
Sangamo Therapeutics, Inc
Orchard Therapeutics
Gilead Lifesciences, Inc.
BENITEC BIOPHARMA
Sibiono GeneTech Co., Ltd
Shanghai Sunway Biotech Co., Ltd.
Gensight Biologics S.A.
Transgene
Calimmune, Inc.
Epeius Biotechnologies Corp.
Astellas Pharma Inc.
American Gene Technologies
BioMarin Pharmaceuticals, Inc.
Others

GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE

Viral Vector
Non-Viral Vector

GLOBAL GENE THERAPY MARKET, BY GENE TYPE

Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Growth factors
Receptors
Others

GLOBAL GENE THERAPY MARKET, BY THERAPY

In Vivo Therapy
Ex Vivo Therapy

GLOBAL GENE THERAPY MARKET, BY APPLICATION

Oncological Disorders
Rare Diseases
Neurological Disorders
Other Diseases

GLOBAL GENE THERAPY MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV2021

1. Gene Therapy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Gene Therapy Market Snippet by Vector Type
- 2.1.2. Gene Therapy Market Snippet by Gene Type
- 2.1.3. Gene Therapy Market Snippet by Therapy
- 2.1.4. Gene Therapy Market Snippet by Application
- 2.1.5. Gene Therapy Market Snippet by Country
- 2.1.6. Gene Therapy Market Snippet by Region
2.2. Competitive Insights

3. Gene Therapy Key Market Trends

3.1. Gene Therapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Gene Therapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Gene Therapy Market Opportunities
3.4. Gene Therapy Market Future Trends

4. Gene Therapy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Gene Therapy Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Gene Therapy Market Landscape

6.1. Gene Therapy Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Gene Therapy Market - By Vector Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Vector Type, 2022 & 2030 (%)
- 7.1.2. Viral Vector
- 7.1.3. Non-Viral Vector

8. Gene Therapy Market - By Gene Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Gene Type, 2022 & 2030 (%)
- 8.1.2. Antigen
- 8.1.3. Cytokine
- 8.1.4. Tumor Suppressor
- 8.1.5. Suicide
- 8.1.6. Deficiency
- 8.1.7. Growth factors
- 8.1.8. Receptors
- 8.1.9. Others

9. Gene Therapy Market - By Therapy

9.1. Overview
- 9.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
- 9.1.2. In Vivo Therapy
- 9.1.3. Ex Vivo Therapy

10. Gene Therapy Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 10.1.2. Oncological Disorders
- 10.1.3. Rare Diseases
- 10.1.4. Neurological Disorders
- 10.1.5. Other Diseases

11. Gene Therapy Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Gene Therapy Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Gene Therapy Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Gene Therapy Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Gene Therapy Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Gene Therapy Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Gene Therapy Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. REGENXBIO, Inc.
- 12.2.2. Oxford BioMedica plc
- 12.2.3. Dimension Therapeutics, Inc.
- 12.2.4. Bristol-Myers Squibb Company
- 12.2.5. SANOFI
- 12.2.6. Applied Genetic Technologies Corporation
- 12.2.7. F. Hoffmann-La Roche Ltd
- 12.2.8. Bluebird Bio, Inc.
- 12.2.9. Novartis AG
- 12.2.10. Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
- 12.2.11. UniQure N.V.
- 12.2.12. Shire Plc
- 12.2.13. Cellectis S.A.
- 12.2.14. Sangamo Therapeutics, Inc
- 12.2.15. Orchard Therapeutics
- 12.2.16. Gilead Lifesciences, Inc.
- 12.2.17. BENITEC BIOPHARMA
- 12.2.18. Sibiono GeneTech Co., Ltd
- 12.2.19. Shanghai Sunway Biotech Co., Ltd.
- 12.2.20. Gensight Biologics S.A.
- 12.2.21. Transgene
- 12.2.22. Calimmune, Inc.
- 12.2.23. Epeius Biotechnologies Corp.
- 12.2.24. Astellas Pharma Inc.
- 12.2.25. American Gene Technologies
- 12.2.26. BioMarin Pharmaceuticals, Inc.
- 12.2.27. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

Product Code: ANV2021

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Gene Therapy Market: Vector Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Vector Type
TABLE Global Gene Therapy Market, by Vector Type 2018-2030 (USD Million)
TABLE Gene Therapy Market: Gene Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Gene Type
TABLE Global Gene Therapy Market, by Gene Type 2018-2030 (USD Million)
TABLE Gene Therapy Market: Therapy Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Therapy
TABLE Global Gene Therapy Market, by Therapy 2018-2030 (USD Million)
TABLE Gene Therapy Market: Application Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Gene Therapy Market, by Application 2018-2030 (USD Million)
TABLE Gene Therapy Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Gene Therapy Market, by Region 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE North America Gene Therapy Market, by Application, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE Europe Gene Therapy Market, by Application, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE Asia Pacific Gene Therapy Market, by Application, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE Latin America Gene Therapy Market, by Application, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
TABLE Middle East and Africa Gene Therapy Market, by Application, 2018-2030 (USD Million)

List of Figures

FIGURE Gene Therapy Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2022
FIGURE Vector Type segment market share analysis, 2022 & 2030
FIGURE Vector Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Gene Type segment market share analysis, 2022 & 2030
FIGURE Gene Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Therapy segment market share analysis, 2022 & 2030
FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Application segment market share analysis, 2022 & 2030
FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Regional segment market share analysis, 2022 & 2030
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE North America Gene Therapy Market share and leading players, 2022
FIGURE Europe Gene Therapy Market share and leading players, 2022
FIGURE Asia Pacific Gene Therapy Market share and leading players, 2022
FIGURE Latin America Gene Therapy Market share and leading players, 2022
FIGURE Middle East and Africa Gene Therapy Market share and leading players, 2022
FIGURE North America market share analysis by country, 2022
FIGURE U.S. Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Canada Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Europe Gene Therapy Market share analysis by country, 2022
FIGURE Germany Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Spain Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Italy Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE France Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE UK Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Russia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Netherlands Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Sweden Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Poland Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of the Europe Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Asia Pacific Gene Therapy Market share analysis by country, 2022
FIGURE India Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE China Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Japan Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE South Korea Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Australia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Thailand Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indonesia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Phillipines Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of APAC Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Gene Therapy Market share analysis by country, 2022
FIGURE Brazil Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Mexico Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Argentina Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Colombia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of LATAM Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Gene Therapy Market share analysis by country, 2022
FIGURE Saudi Arabia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE United Arab Emirates Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Israel Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Turkey Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Algeria Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Egypt Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of MEA Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)

Gene Therapy Market, By Vector Type, By Gene Type, By Therapy, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

Description

Table of Contents

List of Tables

REPORT HIGHLIGHT

Gene Therapy Market- Segmentation Analysis:

Gene Therapy Market- Competitive Landscape:

Recent Developments:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE THERAPY MARKET KEY PLAYERS

GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE

GLOBAL GENE THERAPY MARKET, BY GENE TYPE

GLOBAL GENE THERAPY MARKET, BY THERAPY

GLOBAL GENE THERAPY MARKET, BY APPLICATION

GLOBAL GENE THERAPY MARKET, BY REGION

Table of Contents

1. Gene Therapy Market Overview

2. Executive Summary

3. Gene Therapy Key Market Trends

4. Gene Therapy Industry Study

5. Gene Therapy Market: COVID-19 Impact Analysis

6. Gene Therapy Market Landscape

7. Gene Therapy Market - By Vector Type

8. Gene Therapy Market - By Gene Type

9. Gene Therapy Market - By Therapy

10. Gene Therapy Market - By Application

11. Gene Therapy Market- By Geography

12. Key Vendor Analysis- Gene Therapy Industry

13. 360 Degree Analyst View

14. Appendix

List of Tables

List of Figures